Species
Non-rodents species are essential in preclinical development when additional physiological or metabolic similarity to humans is required. At Vivotecnia, we offer studies in species such as minipigs, and non-human primates, following international regulatory guidelines and ensuring high standards of animal welfare.
Established — 2000
Explore More Below
Our non-rodent programs are managed by expert personnel in dedicated species-specific facilities, with a focus on scientific rigor, ethical practices, and reproducibility of results. Species selection is based on pharmacological relevance, route of administration, and compound-specific charateristics.
Regulatory agencies often require non-rodents to complement rodent studies, particularly in pivotal submissions. Their use provides a broader toxicological profile, especially for compounds with human-specific targets, complex formulations, or particular ADME characteristics.
At Vivotecnia, we support ou clients in selecting the most appropriate non-rodent model for each development stage, balancing scientific requirements with ethical responsibility.
Göttingen minipigs, and non-human primates (NHPs, upon request and in collaboration with accredited facilities)
General and reproductive toxicology, safety pharmacology (CV, respiratory, CNS), toxicokinetics, pharmacokinetics, and long-term dose studies.
We perform studies under GLP, adhering to EU Directive 2010/63, OECD and ICH guidelines, and ensuring ethical review by internal committees.
Our non-rodent units can host up to 250 rabbits, 184 dogs, 416 minipigs and 84 non-human primetes simultaneously, supporting complex study designs and tight timelines.
Our animal care staff, veterinarians and researchers are trained in species-specific procedures, ensuring safety and accuracy throughout the study lifecycle.
Need a non-rodent models for your
regulatory study? Our team will help you
select and manage the most appropriate
species with full regulatory compliance!
